Sort
48,018 grants matching “immunotherapy”
A platform for multi-modal single nucleus spatial genomics for molecular tumor analysis
$413,641Fei Chen · Broad Institute, Inc. · R33 · FY2025 · CA
Targeting exosomal PDL1 to improve immunotherapy
$413,618Wei Guo · Wistar Institute · P50 · FY2023 · CA
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
$413,594Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · CA
CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies
$413,526Gianpietro Dotti · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$413,515Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · AI
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$413,515Drew M. Pardoll · Johns Hopkins University · R01 · FY2020 · AI
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$413,515Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · AI
Direct and indirect impacts of HIV and ART among older people in community settin
$413,497Ties Boerma · World Health Organization · R01 · FY2014 · AG
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$413,478Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2024 · DK
Shared Resource: Therapeutic Manufacturing
$413,458Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2017 · CA
ChNKG2D-Targeted Cellular Cancer Therapy: Preclinical Toxicology
$413,428Carin Marie-Louise Sentman · Celdara Medical, Llc · R43 · FY2010 · HL
Contributions of sleep/rhythms/fatigue to "chemobrain"
$413,397University Of California San Diego · R01 · FY2005 · CA
Regulation of CD8 T Cell Immunity by CDK Inhibitor p27Kip1
$413,355Marulasiddappa Suresh · University Of Wisconsin-Madison · R01 · FY2010 · AI
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$413,341Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2022 · AG
CEA TARGETED IMMUNOTHERAPEUTICS
$413,331Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C
$413,330Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2007 · CA
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$413,325Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · AI
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$413,325Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · AI
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$413,325Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · AI
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$413,286Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies
$413,285Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Disparities in Immuno-oncology Outcomes in Detroit (DIODE)
$413,265Kristen S. Purrington · Wayne State University · P20 · FY2025 · CA